PFN1 and amyotrophic lateral sclerosis: We therefore measured relative PFN1 mRNA abundance and PFN1 protein levels in LCLs of five healthy controls as well as in PFN1 T109M mutant LCLs of two clinically definite ALS patients and three pre-clinical mutation carriers (Fig. 1).